China’s CDE grants breakthrough status approval to Abbisko’s HCC therapy
The China National Medical Products Administration’s (NMPA) Center for Drug Evaluation (CDE) has granted breakthrough therapy designation approval to Abbisko…
Oncology
-
-
CHMP recommends GSK’s Blenrep approval for multiple myeloma treatment
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of GSK’s Blenrep…
-
ASCO25: Roche’s Itovebi combo reduces risk of death in breast cancer by 33%
Roche’s blockbuster vision for phosphoinositide 3-kinase (PI3K inhibitor) Itovebi (inavolisib) has been dealt a boost after the drug demonstrated further…
-
Japan’s MHLW approves GSK’s Blenrep combos for multiple myeloma
The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted approval for the use of GSK’s Blenrep (belantamab mafodotin)…
-
Pfizer signs global licensing deal with 3SBio for bispecific antibody
Pfizer has signed a worldwide licensing agreement, excluding China, with biopharmaceutical company 3SBio to develop, manufacture and commercialise bispecific antibody…
-
EC approves BMS’ perioperative Opdivo and chemo for NSCLC
The European Commission (EC) has granted approval to Bristol Myers Squibb's (BMS) perioperative regimen of neoadjuvant Opdivo (nivolumab), combined with chemotherapy…
-
Pathos AI raises $365m for oncology drug development
Pathos AI has raised $365m in a Series D funding round as it prepares to widen its AI-enabled platform to…
-
Boehringer partners Tempus AI to enhance cancer therapy pipeline
Boehringer Ingelheim has entered a multi-year partnership with Tempus AI to progress its cancer therapy pipeline. The collaboration builds upon…
-
GSK and iTeos drop anti-TIGIT drug following trial failure
GSK and iTeos are the latest companies to scrap a jointly developed anti-TIGIT drug after it failed to demonstrate a…
-
GLP-1RAs show anti-cancer benefits beyond weight loss
A study has found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer anti-cancer benefits that extend beyond their role in promoting…
